Form 8.3

Summary by AI BETAClose X

Qube Research & Technologies Limited disclosed on 03-11-2026 that as at 02-11-2026 it holds 7,970,158 cash-settled derivative positions in Advanced Medical Solutions Group plc, representing 3.60% of the 5p ordinary shares, with no direct holdings or short positions and no stock-settled derivatives or subscription rights; the filing records recent increases in long exposure via equity swaps referencing 18,908 shares transacted at 282.50p, 282.75p and 283.00p, with no indemnities or related arrangements and no Supplemental Form 8 attached.

Disclaimer*

UK 100